A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder
about
Future pharmacological treatments for substance use disordersFurther evidence of association between two NET single-nucleotide polymorphisms with ADHDInsulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasisPharmacological treatments for methamphetamine addiction: current status and future directions.Subcellular localization of the antidepressant-sensitive norepinephrine transporter.Effects of bisphenol-A and other endocrine disruptors compared with abnormalities of schizophrenia: an endocrine-disruption theory of schizophrenia.Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorderSequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.Molecular genetics of attention deficit hyperactivity disorder.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.Pharmacogenetics of antidepressant response.Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters.Possible association of norepinephrine transporter -3081(A/T) polymorphism with methylphenidate response in attention deficit hyperactivity disorderComprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.Regulation of monoamine transporters: Role of transporter phosphorylation.Cytokines inhibit norepinephrine transporter expression by decreasing Hand2Neuroscience of behavioral and pharmacological treatments for addictionsGenetic variation in the presynaptic norepinephrine transporter is associated with blood pressure responses to exercise in healthy humansNovel duplication on chromosome 16 (q12.1-q21) associated with behavioral disorder, mild cognitive impairment, speech delay, and dysmorphic features: case report.Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthoodCholine transporter gene variation is associated with attention-deficit hyperactivity disorder.Genetic variation in alpha2-adrenoreceptors and heart rate recovery after exercise.Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.Analysis of Association between Norepinephrine Transporter Gene Polymorphisms and Personality Traits of NEO-FFI in a Japanese PopulationEffects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETMonoamine transporters: vulnerable and vital doorkeepers.No Evidence for Association Between Norepinephrine Transporter-3081 (A/T) Polymorphism and Attention Deficit Hyperactivity Disorder in Iranian Population.The solute carrier 6 family of transportersPossible effect of norepinephrine transporter polymorphisms on methylphenidate-induced changes in neuropsychological function in attention-deficit hyperactivity disorder.Attention deficit hyperactivity disorder: genetic association study in a cohort of Spanish childrenDifferential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini.Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.Multivariate permutation analysis associates multiple polymorphisms with subphenotypes of major depression.Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function.Rats and humans paying attention: cross-species task development for translational researchMolecular genetics of attention-deficit/hyperactivity disorder: an overviewVesicular and plasma membrane transporters for neurotransmitters.ADHD pharmacogenetics across the life cycle: New findings and perspectives.An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder.Association studies of -3081(A/T) polymorphism of norepinephrine transporter gene with attention deficit/hyperactivity disorder in Korean population.
P2860
Q22242633-E8DC007B-1A69-47FA-B7BA-3728BCFA3420Q28249260-4A4AD91B-5149-45B9-B575-E5F590A27830Q28483930-3E6A80F5-DE44-4CA1-95F5-C7D0982562BCQ30240173-BD7101C8-EFD5-4562-BBC9-40A2C3232D73Q30439090-CB1CC0EF-3A44-48F2-AE4E-7FE6E0AA8513Q30490910-AFD3B470-FC36-43C2-9C30-D36DED5736D8Q33571104-BDC2D47B-38CA-4CE4-BCC7-6267B98F075CQ33710367-5AF5BC47-D62B-4E8E-950B-3591870C9BF3Q33760330-0DD98B23-AD08-4C4E-92BB-45C9170688BCQ33870580-EB008820-7603-4F62-8405-DC327E9E9B8BQ34155796-38565D91-A546-4247-8476-4B6803C7F10FQ34161514-92E71464-3559-4614-B842-5E3646FCE9D6Q34221423-B3BC0EC8-8131-47C8-946A-5816A910F3DEQ34490272-23D8A45A-CEF6-4CCA-A18B-68CF1ADA1334Q34540543-0E56F790-E58E-462E-8AB9-8073FB161429Q34612857-F597FCE2-8782-4480-BCD2-45353F8F3238Q34714494-C81EBBE0-43A1-47C4-A499-2DE0BDEA1247Q34731144-4F9F0D5E-BDB4-4BC2-8FC5-C081FEA30050Q35067434-C624339C-CAEB-456F-B0F0-295C333A4D8CQ35097990-0CCD982D-9324-4719-95D9-6C7DFB7DBAC9Q35187232-E51491C2-990D-4D0C-BF1B-84697A8CEB28Q35658737-C3EEABCE-1F91-4B89-BF2C-BE5DEAB402F3Q35813558-BD2D5186-9A86-4BF8-8FC2-A48BC30C00F3Q35859113-D3F0E7C6-6E28-4DDB-8204-160FE54FEC0DQ35871702-F2007AA2-50A3-40CA-A57E-3FE60965D80CQ35877150-31351DBF-3573-4C4C-947F-A6B090360E03Q36095784-865C3CBB-0E09-4817-9DE0-BA23D2065EBCQ36346899-2A442AEB-7BB2-46BD-AE66-59A9E78029D8Q36430286-C6D6143A-1234-4B82-908D-01EE84AA14B6Q36446301-3776E885-B079-4E61-9F40-A383A4E7D8A9Q36674628-B1920D83-69E1-4CA3-9B0F-8ADADF9FEFD7Q36984772-F7520F40-4F07-41F2-A6EF-A0C096F6F70CQ37161065-85F4692C-C71C-43EC-B492-DB8C5353BDB9Q37203807-EC983E0E-FD46-46ED-9AAC-1A795DCB2117Q37249653-A6346623-97AC-4FD1-867B-AF87B873F84AQ37690166-AD0F2B4A-5574-4ADE-AFC8-B21F58137896Q37971367-0507CABE-5DF8-44CD-AD80-0D1D84E69A4DQ38209972-F9662CAA-3AAA-4FAD-8DFB-00B1293E5652Q38214174-EAB78CEF-5EE5-465B-B7D7-2829437562F4Q38492975-D4466F72-300B-40C2-B9CB-E2022B7E670D
P2860
A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A polymorphism in the norepine ...... deficit hyperactivity disorder
@ast
A polymorphism in the norepine ...... deficit hyperactivity disorder
@en
A polymorphism in the norepine ...... deficit hyperactivity disorder
@nl
type
label
A polymorphism in the norepine ...... deficit hyperactivity disorder
@ast
A polymorphism in the norepine ...... deficit hyperactivity disorder
@en
A polymorphism in the norepine ...... deficit hyperactivity disorder
@nl
prefLabel
A polymorphism in the norepine ...... deficit hyperactivity disorder
@ast
A polymorphism in the norepine ...... deficit hyperactivity disorder
@en
A polymorphism in the norepine ...... deficit hyperactivity disorder
@nl
P2093
P2860
P921
P356
P1476
A polymorphism in the norepine ...... deficit hyperactivity disorder
@en
P2093
Angela H Steele
Bruce M Cohen
Chun-Hyung Kim
David Robertson
Irwin D Waldman
Kwang-Soo Kim
Martin H Teicher
Maureen K Hahn
Michelle S Mazei-Robinson
P2860
P304
P356
10.1073/PNAS.0510836103
P407
P577
2006-12-12T00:00:00Z